Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004578414 | SCV005067122 | pathogenic | Hyper-IgM syndrome type 2 | 2024-01-13 | criteria provided, single submitter | clinical testing | A gross deletion of the genomic region encompassing the full coding sequence of the AICDA gene has been identified. Loss-of-function variants in AICDA are known to be pathogenic (PMID: 11007475). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. A similar copy number variant has been observed in individual(s) with hyper-IgM syndrome (PMID: 16964591). For these reasons, this variant has been classified as Pathogenic. |